The introduction of highly active antiretroviral therapy (HAART) has generated a contrast in
the cardiac manifestations of acquired immunodeficiency syndrome. In developed countries …

Studies published before the introduction of highly active antiretroviral therapy (HAART)
have tracked the incidence and course of human immunodeficiency virus (HIV) infection in …

The introduction of highly active antiretroviral therapy (HAART) has significantly improved
the clinical outcome of HIV disease, with increased survival rates. However, the introduction …

Cardiovascular manifestations of HIV vary according to disease stage, treatment regimen
and geographical location. Common cardiac complications of HIV disease in patients off …

With the advent and widespread use of antiretroviral therapy (ART), the epidemiology of
cardiomyopathy and heart failure (HF) associated with HIV infection is changing. Near …

Cardiovascular complications in the course of human immunodeficiency virus (HIV) infection
are multifactorial and may be caused by the virus itself or by the related opportunistic …

Highly active antiretroviral therapy (HAART) significantly changed the prevalence of the
cardiovascular manifestations of human immunodeficiency virus (HIV)/AIDS. In developed …

The occurrence of cardiovascular illness in the human immunodeficiency virus (HIV)
community is increasing, with a particular focus on coronary heart disease. Patients infected …

From a global perspective, cardiovascular disease (CVD) in human immunodeficiency virus
(HIV) may result from cardiac involvement upon presentation of opportunistic infections in …

Since the introduction of highly active antiretroviral therapy (HAART), AIDS has become a
treatable disease. A steep decline in morbidity and mortality has been observed in most …